- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CD27, also known as TNF receptor superfamily member 7 (TNFRSF7), is a cell surface receptor expressed on T lymphocytes, memory B cells, and subsets of natural killer cells, where it reflects prior antigen exposure and functional immune activation. CD27 Antibody / Antigen-Experienced Lymphocyte Marker Antibody (clone LPFS2/4178) is uniquely positioned for identifying antigen-experienced lymphocyte populations, enabling detection of CD27 as a marker of immune activation history and functional differentiation. CD27 antibody reagents are widely used in immunology research to distinguish antigen-experienced cells from naive populations and to characterize immune response history.
CD27 antibody, also referred to as TNFRSF7 antibody or CD27 antigen-experienced lymphocyte antibody in the literature, is closely associated with lymphocytes that have undergone activation following antigen encounter. Expression of CD27 reflects a transition from naive to antigen-experienced states, marking cells that have participated in immune responses and acquired functional specialization. This makes CD27 a key marker for evaluating immune system experience and adaptive response history.
CD27 Antibody / Antigen-Experienced Lymphocyte Marker Antibody (clone LPFS2/4178) is particularly valuable for analyzing immune cell populations in both tissue and suspension-based assays, where identification of antigen-experienced lymphocytes is critical. Detection of CD27 supports studies of immune activation, differentiation, and functional memory, providing insight into how immune responses develop and are maintained across different biological contexts.
In lymphoid tissues, CD27 expression is enriched in germinal centers and memory compartments, where antigen-experienced lymphocytes are concentrated. In peripheral blood, CD27-positive cells represent populations that have previously encountered antigen and are capable of responding to subsequent stimulation. This distribution supports the use of CD27 as a marker for assessing immune response history and for distinguishing functional lymphocyte subsets.
This clone also benefits from protein microarray specificity validation, supporting selective detection of CD27 and reducing the likelihood of off-target binding in complex samples. This validation adds confidence when interpreting CD27 expression, particularly in experiments where distinguishing antigen-experienced populations is essential.
The mouse monoclonal clone LPFS2/4178 antibody is designed to provide consistent detection of CD27, enabling reliable identification of antigen-experienced lymphocyte populations across experimental systems. Its performance supports reproducible analysis of immune activation history and lymphocyte differentiation.
Overall, CD27 Antibody / Antigen-Experienced Lymphocyte Marker Antibody (clone LPFS2/4178) provides robust detection of CD27 for studies focused on antigen-experienced lymphocytes, immune activation history, and adaptive immune response development.
This antibody is part of a broader CD27 antibody collection designed to support diverse immunological research applications.
Optimal dilution of the CD27 Antibody / Antigen-Experienced Lymphocyte Marker Antibody should be determined by the researcher.
A portion of amino acids 28-170 was used as the immunogen for the CD27 antibody.
Aliquot the CD27 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
TNFRSF7 antibody, CD27 antigen experienced lymphocyte antibody, CD27 specificity validated antibody, CD27 immune activation history marker antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.